Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

Restart enters definitive deal to acquire Holy Crap

HEAL · Price

Executive Summary

  • Restart Life Sciences Corp. has executed a definitive share purchase agreement to acquire 100 % of Holy Crap Foods Inc. for $1 million cash.
  • The transaction includes Holy Crap’s portfolio of consumer‑health brands and its British Columbia manufacturing facility, which will become a wholly‑owned subsidiary of Restart Life.
  • Closing is expected within the next ten business days, subject to customary conditions, and aligns with Restart Life’s strategy to add revenue‑generating, health‑focused consumer brands.

Key Details

  • Purchase Price: $1 million cash (subject to working‑capital adjustments).
  • Seller: Happy Belly Coffee Inc., a subsidiary of Happy Belly Food Group Inc. (CSE: HBFG).
  • Acquired Assets: All issued and outstanding shares of Holy Crap Foods Inc.; brand portfolio; BC‑based manufacturing facility.
  • Closing Timeline: Anticipated within 10 business days after signing, pending customary closing conditions and any post‑closing adjustments per the definitive agreement.
  • Strategic Rationale: Enhances Restart Life’s presence in the wellness consumer market, adds an established revenue base, and provides operational flexibility for current and future product lines.
  • Post‑Closing Plans: Holy Crap to operate as a wholly owned subsidiary; existing operations will be maintained while evaluating expansion, product development, and integration opportunities.
  • Management Commentary: CEO Steve Loutskou highlighted the acquisition’s fit with strategic objectives, the brand’s strong revenue base, and commitment to sustainable, prudent growth.

Notable Quotes

“We believe Holy Crap represents a well‑established brand with an existing revenue base and manufacturing capabilities that complement our long‑term objectives.” – Steve Loutskou, CEO, Restart Life Sciences Corp.

Read the original news release →

More from Restart Life Sciences Corp